JP2022518695A5 - - Google Patents

Info

Publication number
JP2022518695A5
JP2022518695A5 JP2021540809A JP2021540809A JP2022518695A5 JP 2022518695 A5 JP2022518695 A5 JP 2022518695A5 JP 2021540809 A JP2021540809 A JP 2021540809A JP 2021540809 A JP2021540809 A JP 2021540809A JP 2022518695 A5 JP2022518695 A5 JP 2022518695A5
Authority
JP
Japan
Prior art keywords
sequence
referred
peptide ligand
ligand according
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021540809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518695A (ja
Filing date
Publication date
Priority claimed from GBGB1900525.5A external-priority patent/GB201900525D0/en
Application filed filed Critical
Publication of JP2022518695A publication Critical patent/JP2022518695A/ja
Publication of JP2022518695A5 publication Critical patent/JP2022518695A5/ja
Pending legal-status Critical Current

Links

JP2021540809A 2019-01-15 2020-01-15 Caixに特異的な二環式ペプチドリガンド Pending JP2022518695A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1900525.5A GB201900525D0 (en) 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for caix
GB1900525.5 2019-01-15
PCT/GB2020/050069 WO2020148525A1 (en) 2019-01-15 2020-01-15 Bicyclic peptide ligands specific for caix

Publications (2)

Publication Number Publication Date
JP2022518695A JP2022518695A (ja) 2022-03-16
JP2022518695A5 true JP2022518695A5 (cg-RX-API-DMAC7.html) 2023-01-25

Family

ID=65528179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021540809A Pending JP2022518695A (ja) 2019-01-15 2020-01-15 Caixに特異的な二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220088118A1 (cg-RX-API-DMAC7.html)
EP (1) EP3911665A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022518695A (cg-RX-API-DMAC7.html)
CN (1) CN113383007A (cg-RX-API-DMAC7.html)
GB (1) GB201900525D0 (cg-RX-API-DMAC7.html)
WO (1) WO2020148525A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头
EP4448544A2 (en) * 2021-12-17 2024-10-23 3B Pharmaceuticals GmbH Carbonic anhydrase ix ligands
EP4321526A4 (en) * 2022-02-11 2026-04-15 C Biomex Co Ltd Peptide ligand targeting carbonic anhydrase IX, peptide construction comprising it, and associated uses
AU2024298898A1 (en) * 2023-07-25 2025-11-27 C-Biomex Co., Ltd. Peptide structure targeting carbonic dehydrogenase ix and use thereof
CN120943901A (zh) * 2025-05-29 2025-11-14 北京肿瘤医院(北京大学肿瘤医院) 经修饰的caix靶向环肽、核素标记物及其在肿瘤诊疗方面的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
EP3615550A1 (en) * 2017-04-27 2020-03-04 BicycleTx Limited Bicyclic peptide ligands and uses thereof
WO2019002842A1 (en) * 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2022517442A5 (cg-RX-API-DMAC7.html)
JP2022517040A5 (cg-RX-API-DMAC7.html)
JP2022512478A5 (cg-RX-API-DMAC7.html)
JP2022514687A5 (cg-RX-API-DMAC7.html)
JP2022514255A5 (cg-RX-API-DMAC7.html)
JP2022517698A5 (cg-RX-API-DMAC7.html)
JP2022513223A5 (cg-RX-API-DMAC7.html)
JP2022518210A5 (cg-RX-API-DMAC7.html)
JP2022544058A5 (cg-RX-API-DMAC7.html)
JP2022513806A5 (cg-RX-API-DMAC7.html)
JP2022532134A5 (cg-RX-API-DMAC7.html)
JP2022515720A5 (cg-RX-API-DMAC7.html)
JP2022552839A5 (cg-RX-API-DMAC7.html)
JP2022542291A5 (cg-RX-API-DMAC7.html)
US7718610B2 (en) Retrocyclins: antiviral and antimicrobial peptides
JP2007534698A5 (cg-RX-API-DMAC7.html)
JP2020524163A5 (ja) ペプチド組成物
JP2006506942A5 (cg-RX-API-DMAC7.html)
Redman et al. Pharmacokinetic and chemical synthesis optimization of a potent D-peptide HIV entry inhibitor suitable for extended-release delivery
JP2023549229A5 (cg-RX-API-DMAC7.html)
JP2017501132A (ja) Psd−95の二量体阻害剤脂肪酸誘導体
JP2022515721A5 (cg-RX-API-DMAC7.html)
JP2012517425A5 (cg-RX-API-DMAC7.html)
JP2024515306A5 (cg-RX-API-DMAC7.html)
JP2019038772A5 (cg-RX-API-DMAC7.html)